This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Endocrine disorders
Endocrine disorders
Vandetanib shows positive results
European Commission grants marketing authorisation for VPRIV
Treating the hyperthyroid patient with radioiodine
FDA calls for conflict inquiry
Plant problems hit Genzyme output
Shire receives CHMP Positive Opinion for VPRIV the treatment of Type 1 Gaucher Disease
Results of Zeta study presented at ASCO
Gaucher-fighting drug for Europe
Shire to present important study findings for gaucher disease treatment
Stress drugs ‘must work with body’
HRA Pharma Expands to Spain and Launches ellaOne
Shire bids for Gaucher approval
« Previous
1
2
3
4
5
6
7
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: